BRTX BioRestorative Therapies, Inc.
Healthcare$0.25+20.10%ClosedMarket Cap: $2.2M
As of 2026-05-26
Insider Statistics (Q2 2024)
Acquisitions
3
Dispositions
0
Buy/Sell Ratio
0.00
Net Shares
+8,308
Shares Acquired
8,308
Shares Disposed
0
Total Bought ($)
$3.00
Total Sold ($)
$0.00
Recent Insider Trades
| Filing Date | Name | Type | Action | Shares | Price | Shares After |
|---|---|---|---|---|---|---|
| Mon Oct 20 | Silva Francisco | director, officer: VP of Research and Development | Sell | 11,719 | $1.60 | 171,384 |
| Mon Oct 20 | ALSTODT LANCE | director, 10 percent owner, officer: President, CEO, COB | Sell | 15,625 | $1.60 | 187,497 |
| Mon Oct 20 | ALSTODT LANCE | director, 10 percent owner, officer: President, CEO, COB | Sell | 11,719 | $2.75 | 11,719 |
| Wed Feb 19 | Williams Patrick F. | director | Sell | 52,632 | $2.46 | 52,632 |
| Wed Feb 19 | Silva Francisco | director, officer: VP of Research and Development | Sell | 768,979 | $2.46 | 768,979 |
| Wed Feb 19 | Rosa David A | director | Sell | 52,632 | $2.46 | 52,632 |
| Wed Feb 19 | Kukekov Nickolay V. | director | Sell | 52,632 | $2.46 | 52,632 |
| Wed Feb 19 | Kristal Robert Eugene | officer: Chief Financial Officer | Sell | 166,492 | $2.46 | 166,492 |
| Wed Feb 19 | ALSTODT LANCE | director, officer: President, CEO, COB | Sell | 791,885 | $2.46 | 791,885 |